Literature DB >> 17486397

Left ventricular mass in 169 healthy children and young adults assessed by three-dimensional echocardiography.

T Poutanen1, E Jokinen.   

Abstract

The aims of this study were to establish normal values of left ventricular (LV) mass in children and young adults using three-dimensional echocardiography (3-DE) and to compare 3-DE LV mass estimates with those obtained by conventional echocardiographic methods. We studied 169 healthy subjects aged 2-27 years by digitized 3-D, two-dimensional (2-D), and M-mode echocardiography. 3-D echocardiography was performed by using rotational acquisition of planes at 18 degrees intervals from apical view with ECG gating and without respiratory gating. 3-DE gave smaller LV mass estimates than 2-DE and M-mode echocardiography (p < 0.001). Agreement analysis resulted in a bias of -9.3 +/- 36.5 g between 3-DE and 2-DE, and -18.5 +/- 47.9 g between 3-DE and M-mode. For the analysis, the subjects were divided into five groups according to body surface area (BSA): 0.5-0.75, 0.75-1.0, 1.0-1.25, 1.25-1.5, and greater than 1.5 m(2). LV mass/BSA by 3-DE was 45.6 (5.1), 54.3 (7.7), 55.2 (7.9), 58.8 (8.1), and 65.0 (9.9) g/m(2). LV mass/end diastolic volume (EDV) by 3-DE was 0.9 (0.1) g/ml in the BSA group of 0.5-0.75 m(2) and 1.0 (0.2) g/ml in the other BSA groups. LV mass increased linearly in relation to BSA, height, and body mass (r = 0.93, 0.90, and 0.92, respectively; p < 0.001 for all). The results showed a linear increase in LV mass, whereas LV mass/EDV ratio remained unchanged. However, LV mass estimates by 3-DE were lower than those obtained by 2-DE and M-mode echocardiography. The data obtained by 3-DE from 169 healthy subjects will serve as a reference for further studies in patients with various cardiac abnormalities.

Entities:  

Mesh:

Year:  2007        PMID: 17486397     DOI: 10.1007/s00246-006-0101-5

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  51 in total

1.  Secondary harmonic imaging overestimates left ventricular mass compared to fundamental echocardiography.

Authors:  A D McGavigan; F G Dunn; N E R Goodfield
Journal:  Eur J Echocardiogr       Date:  2003-09

Review 2.  Assessment of left ventricular function with contrast echocardiography.

Authors:  R Parker Ward; Victor Mor-Avi; Roberto M Lang
Journal:  Cardiol Clin       Date:  2004-05       Impact factor: 2.213

3.  A formula to estimate the approximate surface area if height and weight be known. 1916.

Authors:  D Du Bois; E F Du Bois
Journal:  Nutrition       Date:  1989 Sep-Oct       Impact factor: 4.008

Review 4.  Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms.

Authors:  N B Schiller; P M Shah; M Crawford; A DeMaria; R Devereux; H Feigenbaum; H Gutgesell; N Reichek; D Sahn; I Schnittger
Journal:  J Am Soc Echocardiogr       Date:  1989 Sep-Oct       Impact factor: 5.251

5.  Left heart volume estimation in infancy and childhood. Reevaluation of methodology and normal values.

Authors:  T P Graham; J M Jarmakani; R V Canent; M N Morrow
Journal:  Circulation       Date:  1971-06       Impact factor: 29.690

6.  Canine left ventricular mass estimation by two-dimensional echocardiography.

Authors:  N B Schiller; C G Skiôldebrand; E J Schiller; C C Mavroudis; N H Silverman; S H Rahimtoola; M J Lipton
Journal:  Circulation       Date:  1983-07       Impact factor: 29.690

7.  Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk.

Authors:  G de Simone; R B Devereux; S R Daniels; M J Koren; R A Meyer; J H Laragh
Journal:  J Am Coll Cardiol       Date:  1995-04       Impact factor: 24.094

8.  Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight.

Authors:  G de Simone; S R Daniels; R B Devereux; R A Meyer; M J Roman; O de Divitiis; M H Alderman
Journal:  J Am Coll Cardiol       Date:  1992-11-01       Impact factor: 24.094

9.  Determination of left ventricular mass by echocardiography in a normal population: effect of age and sex in addition to body size.

Authors:  C Shub; A L Klein; P K Zachariah; K R Bailey; A J Tajik
Journal:  Mayo Clin Proc       Date:  1994-03       Impact factor: 7.616

10.  Gender differences in left ventricular growth.

Authors:  G de Simone; R B Devereux; S R Daniels; R A Meyer
Journal:  Hypertension       Date:  1995-12       Impact factor: 10.190

View more
  11 in total

1.  The Prevalence of Left Ventricular Hypertrophy in Obese Children Varies Depending on the Method Utilized to Determine Left Ventricular Mass.

Authors:  Joseph Mahgerefteh; Jarrett Linder; Ellen J Silver; Penelope Hazin; Scott Ceresnak; Daphne Hsu; Leo Lopez
Journal:  Pediatr Cardiol       Date:  2016-03-31       Impact factor: 1.655

2.  Mucopolysaccharidosis: cardiologic features and effects of enzyme-replacement therapy in 24 children with MPS I, II and VI.

Authors:  Marion M M G Brands; Ingrid M Frohn-Mulder; Marloes L C Hagemans; Wim C J Hop; Esmee Oussoren; Wim A Helbing; Ans T van der Ploeg
Journal:  J Inherit Metab Dis       Date:  2012-01-26       Impact factor: 4.982

3.  Enzyme therapy and immune response in relation to CRIM status: the Dutch experience in classic infantile Pompe disease.

Authors:  Carin M van Gelder; Marianne Hoogeveen-Westerveld; Marian A Kroos; Iris Plug; Ans T van der Ploeg; Arnold J J Reuser
Journal:  J Inherit Metab Dis       Date:  2014-04-09       Impact factor: 4.982

4.  Cardiac features and effects of enzyme replacement therapy in Taiwanese patients with Mucopolysaccharidosis IVA.

Authors:  Hsiang-Yu Lin; Ming-Ren Chen; Shan-Miao Lin; Chung-Lieh Hung; Dau-Ming Niu; Chih-Kuang Chuang; Shuan-Pei Lin
Journal:  Orphanet J Rare Dis       Date:  2018-08-29       Impact factor: 4.123

5.  Effects of immunomodulation in classic infantile Pompe patients with high antibody titers.

Authors:  E Poelman; M Hoogeveen-Westerveld; J M P van den Hout; R G M Bredius; A C Lankester; G J A Driessen; S S M Kamphuis; W W M Pijnappel; A T van der Ploeg
Journal:  Orphanet J Rare Dis       Date:  2019-03-22       Impact factor: 4.123

Review 6.  EDUCATIONAL SERIES IN CONGENITAL HEART DISEASE: Three-dimensional echocardiography in congenital heart disease.

Authors:  John M Simpson; Annemien van den Bosch
Journal:  Echo Res Pract       Date:  2019-05-13

7.  Long-term galsulfase enzyme replacement therapy in Taiwanese mucopolysaccharidosis VI patients: A case series.

Authors:  Hsiang-Yu Lin; Chih-Kuang Chuang; Chung-Hsing Wang; Yin-Hsiu Chien; Yu-Mei Wang; Fuu-Jen Tsai; Yen-Yin Chou; Shio Jean Lin; Hui-Ping Pan; Dau-Ming Niu; Wuh-Liang Hwu; Yu-Yuan Ke; Shuan-Pei Lin
Journal:  Mol Genet Metab Rep       Date:  2016-04-18

8.  Aerobic Training after Myocardial Infarction: Remodeling Evaluated by Cardiac Magnetic Resonance.

Authors:  Nataly Lino Izeli; Aurélia Juliana Dos Santos; Júlio César Crescêncio; Ana Clara Campagnolo Real Gonçalves; Valéria Papa; Fabiana Marques; Antônio Pazin-Filho; Lourenço Gallo-Júnior; André Schmidt
Journal:  Arq Bras Cardiol       Date:  2016-03-08       Impact factor: 2.000

9.  Effects of a higher dose of alglucosidase alfa on ventilator-free survival and motor outcome in classic infantile Pompe disease: an open-label single-center study.

Authors:  C M van Gelder; E Poelman; I Plug; M Hoogeveen-Westerveld; N A M E van der Beek; A J J Reuser; A T van der Ploeg
Journal:  J Inherit Metab Dis       Date:  2016-01-14       Impact factor: 4.982

Review 10.  Racial Variation in Echocardiographic Reference Ranges for Left Chamber Dimensions in Children and Adolescents: A Systematic Review.

Authors:  Edith D Majonga; Gabrielle Norrish; Andrea M Rehman; Katharina Kranzer; Hilda A Mujuru; Kusum Nathoo; Jon O Odland; Juan P Kaski; Rashida A Ferrand
Journal:  Pediatr Cardiol       Date:  2018-04-04       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.